FDA approved new drug treatment for chronic weight management, first since 2014
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
On Jun. 4, 2021, the U.S. Food and Drug Administration approved Novo Nordisk’s Wegovy (semaglutide) injection (2.4 mg…
On Dec. 4, 2020, Novo Nordisk announced that the FDA approved an updated label for Saxenda (liraglutide) injection…
On Nov. 4, 2020, scientists at the University of Oxford announced they had discovered that obesity can increase…
On Oct. 13, 2020, the National Institute on Drug Abuse (NIDA) and nine other institutes, all part of…
On Sept. 15, 2020, a team of scientists in the U.S. Department of Agriculture’s (USDA) Agriculture Research Service…
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
On Jul. 27, 2020, Albert Einstein College of Medicine announced that it had received a $9.5 million, five-year…
On Aug. 24, 2018, the Cancer Prevention and Research Institute of Texas (CPRIT) announced it passed a $2…
On Dec. 23, 2014, the U.S. Food and Drug Administration (FDA) approved a formulation of Novo Nordisk’s diabetes drug, liraglutide,…
In 2006, Texas Biomed researchers published a genetic linkage map for the rhesus monkey. In 1999, Texas Biomed…
On Nov. 10, 2005, Stanford researchers announced they had discovered obestatin, a hormone that suppresses appetite. The discovery…
On Oct. 11, 2005, the National Cancer Institute announced the Transdisciplinary Research on Energetics and Cancer (TREC) initiative…
On May 11, 2004, the University of Alabama Medical Center’s opened a new $13.5 million 77,000 square foot…
On Oct. 8, 2003, an obesity working group was established by the Commissioner of Food and Drugs, charged…
On Aug. 30, 1999, Dr. Ute Hochgeswender, Development Biology Research Program from the Oklahoma Medical Research Foundation (OMRF)…
In 1999, Texas Biomed researchers published the baboon gene map, the first genetic linkage of a nonhuman primate….
On Sept. 15, 1997, Wyeth-Ayerst Laboratories and Interneuron Pharmaceuticals, manufacturers of the popular off-label obesity combination therapy known…
On Sept. 9, 1986, the U.S. Centers for Disease Control and Prevention (CDC) co-sponsored the first National Conference…
On Apr. 1, 1976, physician and scientist C. Ronald Kahn from Harvard University announced he had discovered alterations…
In 1971, the University of Alabama at Birmingham Comprehensive Cancer Center (UAB) was founded and received its NCI…
In 1968, Stanford Medicine researchers discovered that insulin resistance is the principal physiologic characteristic of mild type-II diabetes…